Funamoto, M.; Sunagawa, Y.; Gempei, M.; Shimizu, K.; Katanasaka, Y.; Shimizu, S.; Hamabe-Horiike, T.; Appendino, G.; Minassi, A.; Koeberle, A.;
et al. Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex. Pharmaceutics 2022, 14, 1269.
https://doi.org/10.3390/pharmaceutics14061269
AMA Style
Funamoto M, Sunagawa Y, Gempei M, Shimizu K, Katanasaka Y, Shimizu S, Hamabe-Horiike T, Appendino G, Minassi A, Koeberle A,
et al. Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex. Pharmaceutics. 2022; 14(6):1269.
https://doi.org/10.3390/pharmaceutics14061269
Chicago/Turabian Style
Funamoto, Masafumi, Yoichi Sunagawa, Mai Gempei, Kana Shimizu, Yasufumi Katanasaka, Satoshi Shimizu, Toshihide Hamabe-Horiike, Giovanni Appendino, Alberto Minassi, Andreas Koeberle,
and et al. 2022. "Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex" Pharmaceutics 14, no. 6: 1269.
https://doi.org/10.3390/pharmaceutics14061269
APA Style
Funamoto, M., Sunagawa, Y., Gempei, M., Shimizu, K., Katanasaka, Y., Shimizu, S., Hamabe-Horiike, T., Appendino, G., Minassi, A., Koeberle, A., Komiyama, M., Mori, K., Hasegawa, K., & Morimoto, T.
(2022). Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex. Pharmaceutics, 14(6), 1269.
https://doi.org/10.3390/pharmaceutics14061269
